Harrow Health(HROW) - 2020 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 45-0567010 (State or other jurisdiction of incorporation or organization) 102 Woodmont Blvd., Suite 610 Nashville, Tennessee 37205 (Address of principal executive offices) (Zip code) (615) 733-47 ...